Safer use of MAOIs with nifedipine to counteract potential hypertensive crisis.
Hesselink
J M
JM
D000286:Administration, Sublingual; D006801:Humans; D006973:Hypertension / Q000139:chemically induced / Q000517:prevention & control*; D008996:Monoamine Oxidase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D009543:Nifedipine / Q000008:administration & dosage* / Q000493:pharmacokinetics
D008996:Monoamine Oxidase Inhibitors; D009543:Nifedipine